130115-07-0

Basic information

• Product Name: (R)-2-(t-butyldimethylsilyloxy)-2-phenylacetaldehyde
• Synonyms: (R)-2-(t-butyldimethylsilyloxy)-2-phenylacetaldehyde
• CAS NO: 130115-07-0
• Molecular Weight: 250.413
• Mol File: 130115-07-0.mol

Chemical Properties

• CAS DataBase Reference: (R)-2-(t-butyldimethylsilyloxy)-2-phenylacetaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2-(t-butyldimethylsilyloxy)-2-phenylacetaldehyde(130115-07-0)
• EPA Substance Registry System: (R)-2-(t-butyldimethylsilyloxy)-2-phenylacetaldehyde(130115-07-0)

Safety Data

• Hazardous Substances Data: 130115-07-0(Hazardous Substances Data)

Upstream product

• 10606-72-1 (R)-mandelic acid ethyl ester 
• 100-52-7 benzaldehyde 
• 10020-96-9 (R)-Mandelonitrile 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 20698-91-3 (R)-methyl mandelate 
• 611-71-2 (R)-Mandelic Acid 
• 153293-97-1 ethyl (R)-2-(tert-butyldimethylsilyloxy)-2-phenylacetate 
• 124876-74-0 Methyl (R)-(-)-α-<<(1,1-dimethylethyl)dimethylsilyl>oxy>-α-phenylacetate 
• 120390-75-2 (R)-(+)-α-<(tert-butyldimethylsilyl)oxy>-benzeneacetonitrile 

Downstream Products

• 153291-93-1 N-[2-(4-methoxycarbonylmethylphenoxy)-1(R)-methylethyl]-2(R)-t-butyldimethylsilyloxy-2-phenylethanamine 
• 54910-89-3 (R)-fluoxetine 
• 105314-52-1 (R)-tomoxetine 
• 112066-67-8 (R)-N-methyl-3-(2-methoxyphenoxy)-3-phenyl-1-propanamine 
• 1453857-64-1 (S)-3-(tert-butyldimethylsilylyloxy)-3-phenylpropan-1-ol 
• 1453857-66-3 (S)-3-(tert-butyldimethylsilyloxy)-3-phenylpropyl methanesulfonate 
• 1453857-68-5 (S)-3-(tert-butyldimethylsilyloxy)-N-methyl-3-phenylpropan-1-amine 
• 114133-37-8 (S)-N-methyl-3-amino-1-phenyl-1-propanol 

Relevant articles and documents

Enantioselective Synthesis of the C23–C33 Fragment of Aetheramide A and Its C32 Epimer

The key aetheramide A intermediate with the natural (R,R,R) configuration along with the one having the unnatural (R,S,R) configuration was synthesized. The synthesis of both stereoisomers was accomplished by Suzuki coupling of two advanced chiral building blocks: (R,R)- and (R,S)-vinylboronates and an (R)-iodoalkene. The former was prepared from (R)-mandelic acid, and the latter was prepared by enantioselective allylation of 3-iodoacrylaldehyde.

Catalyst-Controlled Multicomponent Aziridination of Chiral Aldehydes

A highly diastereoselective and enantioselective method for the multicomponent aziridination of chiral aldehydes has been developed with BOROX catalysts of the VANOL (3,3′-diphenyl-2,2′-bi-1-naphthol) and VAPOL (2,2′-diphenyl-(4-biphenanthrol)) ligands. Very high to perfect catalyst control is observed with most all substrates examined including aldehydes with chiral centers in the α- and β-positions. High catalyst control was also observed for a number of chiral heterocyclic aldehydes allowing for the preparation of epoxy aziridines, bis(aziridines) and ethylene diaziridines. Application of this reaction in the synthesis of β3-homo-d-alloisoleucine and β3-homo-l-isoleucine is reported.

Stereodivergent synthesis of all the four stereoisomers of antidepressant reboxetine

Chiral amino alcohol-copper(ii) catalysts Cu-L1c and Cu-ent-L1c were utilized to promote the diastereoselective nitroaldol reactions of chiral aldehydes (S)-3 or (R)-3 with nitromethane, which respectively led to the preferential formation of certain stereoisomer for nitro diol derivatives 4. Using this catalytic protocol, all the four stereoisomers of the antidepressant reboxetine were divergently prepared. The highest overall yield of this synthetic route reached up to 30.5% from aldehyde (S)-3.

An asymmetric pericyclic cascade approach to 3-alkyl-3-aryloxindoles: Generality, applications and mechanistic investigations

The reaction of L-serine derived N-arylnitrones with alkylarylketenes generates asymmetric 3-alkyl-3-aryloxindoles in good to excellent yields (up to 93%) and excellent enantioselectivity (up to 98% ee) via a pericyclic cascade process. The optimization, scope and applications of this transformation are reported, alongside further synthetic and computational investigations. The preparation of the enantiomer of a Roche anti-cancer agent (RO4999200) 1 (96% ee) in three steps demonstrates the potential utility of this methodology.

Chemoenzymatic asymmetric synthesis of fluoxetine, atomoxetine, nisoxetine, and duloxetine

The asymmetric synthesis of two well-known anti-depressant drugs, fluoxetine and duloxetine has been accomplished in a chemoenzymatic manner. The main highlight of the synthesis is the enantioselective cyanohydrin formation by a plant (R)-HNL (hydroxynitrile lyase). The enantiopure cyanohydrins are then synthetically manipulated into the above two drug molecules and two of their structural analogues, atomoxetine and nisoxetine.

Concise stereoselective total synthesis of leiocarpin C

A simple and highly concise strategy has been developed for the stereoselective total synthesis of leiocarpin C starting from commercially available mandelic ester. The strategy utilizes the OsO4-catalyzed cis-hydroxylation and selective reduction with K-Selectride as key steps. Copyright

First total synthesis of (+)-crassalactone A

A simple and highly efficient first total synthesis of cytotoxic (+)-crassalactone A starting from (R)-mandelic acid is described. The strategy involves the osmium tetroxide-catalyzed cis-hydroxylation and the stereoselective addition of ethyl lithiopropi

Highly enantioselective hydrogenation of aryl vinyl ketones to allylic alcohols catalyzed by the tol-binap/Dmapen ruthenium(II) complex

(Chemical Equation Presented) Binap catalyst doesn't dmapen expectations: In basified 2-propanol, [RuCl2{(S)-tol-binap}{(R)-dmapen}] (1, see picture, Ar=4-CH3C6H4) catalyzes the highly enantioselective hydrogenation of a series of aryl vinyl ketones and affords the allylic alcohols in high yields with up to 98% ee. Formation of the saturated ketones and alcohols is suppressed with triphenylphosphine when necessary.

Concise total synthesis of (+)-goniofufurone and goniobutenolides A and B

Cytotoxic styryl lactones, (+)-goniofufurone and goniobutenolides A and B have been prepared in optically and diastereometically pure form from (R)-(- )-mandelic acid via the β-hydroxy sulfone 4 as a common intermediate.

Easy access to an enantiopure precursor of (+)-goniodiol

Asymmetric synthesis of the epoxide 2 has been achieved from (R)-mandelic acid 3 via highly diastereoselective Wittig reaction and erythro-selective OsO4 catalyzed cis-hydroxylation as key steps. Copyright (C) Elsevier Science Ltd.